NPO Petrovax Pharm cooperates with leading Russian and international research institutes and pharmaceutical companies to develop new products as well as transfer full-cycle drug manufacturing technologies.

Petrovax Pharm’s R&D activities have been based at the Institute of Immunology — State Research Center of Russia’s Federal Medical and Biological Agency (FMBA). Effective collaboration continues presently as well.

For over 20 years, Petrovax Pharm has partnered with the Research Institute of Influenza, the Scientific Children’s Health Center of the Russian Academy of Medical Sciences, and the Research Institute for Pediatric Infections of Russia’s FMBA in innovative influenza vaccine studies.

Petrovax Pharm and St. Petersburg Research Institute for Vaccines and Sera of Russia’s FMBA developed and implemented a highly purified influenza antigen manufacturing technology without mercury preservatives. Due to this project, since 2016, all Grippol® plus ingredients have been manufactured in Russia.